Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flexion Therapeutics Inc (NASDAQ:FLXN)

18.02
Delayed Data
As of Sep 23
 +0.24 / +1.35%
Today’s Change
7.56
Today|||52-Week Range
25.88
-6.49%
Year-to-Date
3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions
Sep 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close17.78
Today’s open17.76
Day’s range17.61 - 18.25
Volume231,340
Average volume (3 months)368,723
Market cap$495.9M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-9.14%
Earnings growth (this year)-28.60%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.74

Competitors

 Today’s
change
Today’s
% change
CYNACynapsus Therapeutic...0.000.00%
OMEROmeros Corp-0.26-2.18%
NERVMinerva Neuroscience...+0.02+0.14%
RVNCRevance Therapeutics...-0.33-1.85%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$0.00
Annual profit (last year)-$46.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael D. Clayman
Chief Financial Officer
Frederick W. Driscoll
Corporate headquarters
Burlington, Massachusetts

Forecasts

Search for Jobs